<DOC>
<DOCNO>EP-0624599</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Derivatives of mono (6-amino-desoxy)cyclodextrin substituted in position 6 with an alpha aminoacid group, process of their preparation and applications
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K841	A61Q1900	C07C32359	C08B3700	C07C22922	A61Q700	A61K842	C07C27100	A61Q700	A61K872	C07C27122	A61K849	C07C32300	C08B3716	A61K830	A61K800	A61K872	A61Q500	A61K844	A61Q1900	A61K873	A61K4740	A61Q500	C07C22900	A61K4740	A61K800	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61Q	C07C	C08B	C07C	A61Q	A61K	C07C	A61Q	A61K	C07C	A61K	C07C	C08B	A61K	A61K	A61K	A61Q	A61K	A61Q	A61K	A61K	A61Q	C07C	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K8	A61Q19	C07C323	C08B37	C07C229	A61Q7	A61K8	C07C271	A61Q7	A61K8	C07C271	A61K8	C07C323	C08B37	A61K8	A61K8	A61K8	A61Q5	A61K8	A61Q19	A61K8	A61K47	A61Q5	C07C229	A61K47	A61K8	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Derivatives of mono(6-amino-6-deoxy)cyclodextrin substituted in position 6 by an  alpha -aminoacid residue. These derivatives correspond to the following general formula: 
<
IMAGE
>
  in which:     CD denotes  alpha ,  beta  or  gamma -cyclodextrin   n is 0 or 1, and   Z denotes a divalent radical chosen from:       (i) -CH2-   (ii) -O-CH2-   (iii) -S-CH2-,   (iv) 
<
IMAGE
>
  and   (v) -O-C6H4-CH2-.   These derivatives find an application for the preparation of inclusion complexes of active substances and may be employed in various fields in particular in cosmetics, in dermatology and in pharmacy.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
OREAL
</APPLICANT-NAME>
<APPLICANT-NAME>
L'OREAL
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
GALONS HERVE
</INVENTOR-NAME>
<INVENTOR-NAME>
GNAIM JALLAL
</INVENTOR-NAME>
<INVENTOR-NAME>
MAIGNAN JEAN
</INVENTOR-NAME>
<INVENTOR-NAME>
GALONS, HERVE
</INVENTOR-NAME>
<INVENTOR-NAME>
GNAIM, JALLAL
</INVENTOR-NAME>
<INVENTOR-NAME>
MAIGNAN, JEAN
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Mono(6-amino-6-deoxy)cyclodextrin derivatives 
substituted in the 6-position by an α-amino acid residue, 

characterized in that they correspond to the following 
general formula: 


 
in which: 


CD represents α-, β- or γ-cyclodextrin, 
n is 0 or 1, and 
Z represents a divalent radical chosen from: 

(i)    -CH
2
-
(ii)    -O-CH
2
-
(iii)    -S-CH
2
-,
 
and 


(v)    -O-C
6
H
4
-CH
2
-
 
with the exclusion of the compounds of formula (I) in 

which CD represents β-cyclodextrin, n = 1 and Z = -CH
2
-. 
Cyclodextrin derivatives according to Claim 1, 
characterized in that the cyclodextrin is β-cyclodextrin. 
Cyclodextrin derivatives according to either of 
Claims 1 and 2, characterized in that they are chosen 

from: 

mono-6-[N-(3-amino-3-carboxypropionyl)-amino]deoxy-β-cyclodextrin, 

and 
mono-6-[N(4-(2'-amino-2'-carboxyethyl)-phenyloxymethyl-1-carbonyl)amino]deoxy-β-cyclodextrin. 
Process for the preparation of the cyclodextrin 
derivatives according to Claims 1 to 3, characterized in 

that an α-aminodicarboxylic acid, the α-amino acid 
functional group of which has been protected and which 

has the following formula: 

 
in which: 


Z and n are as defined in Claim 1, 
R
1
 represents the tert-butyl radical or the benzyl 
radical, and 
R
2
 represents the methyl radical or the benzyl radical, 
is reacted in solution in an organic solvent with a 

mono(6-amino-6-deoxy)cyclodextrin of formula: CDNH
2
 
in which: CD is as defined in Claim 1, the reaction being 

carried out in the presence of 1-hydroxybenzotriazole and 
of dicyclohexylcarbodiimide, and in that the protected 

α-amino acid functional group is then deprotected. 
Process according to Claim 4, characterized in 
that the organic solvent is dimethylformamide. 
Process according to Claim 4 or 5, characterized 
in that the 1-hydroxybenzotriazole is used in a molar 

excess not exceeding 20% with respect to the protected 
α-aminodicarboxylic acid and the dicyclohexylcarbodiimide 

in a molar excess not exceeding 30% with respect to the 
protected α-aminodicarboxylic acid. 
Process according to any one of Claims 4 to 6, 
characterized in that the molar ratio of the mono(6-amino-6-deoxy)cyclodextrin 

to the protected α-aminodicarboxylic 
acid is between 1 and 1.5. 
Process according to any one of Claims 4 to 7, 
characterized in that the mono(6-amino-6-deoxy)cyclodextrin 

is mono(6-amino-6-deoxy)-β-cyclodextrin. 
Process according to any one of Claims 4 to 8, 
characterized in that the deprotection is carried out by 

hydrogenation in the presence of Pd/C (5 to 10%) when R
1
  
 

and R
2
 represent a benzyl radical in the formula (
2
). 
Process according to any one of Claims 4 to 8, 
characterized in that deprotection is carried out in the 

presence of trifluoroacetic acid when R
1
 represents a 
tert-butyl radical in the formula (
2
), deprotection of 
the ester functional group being obtained by 

saponification in the presence of sodium hydroxide. 
Process according to any one of Claims 4 to 9, 
characterized in that the protected α-aminodicarboxylic 

acid is chosen from: 

benzyl N-(benzyloxycarbonyl)aspartate, 
benzyl N-(benzyloxycarbonyl)glutamate, and 
methyl N-(tert-butyloxycarbonyl)-O-(carboxymethyl)tyrosinate. 
Intermediates in the synthesis of the cyclodextrin 
derivatives, characterized in that they correspond 

to the following general formula: 

 
in which: 


R represents a hydrogen atom or the benzyl radical, 
R
1
 represents the tert-butyl radical or the benzyl 
radical, 
R
2
 represents the methyl radical or the benzyl radical, 
and 
Z' represents a divalent radical chosen from: 

(i)    -O-CH
2
-
(ii)    -S-CH
2
-
 
and 


(iv)    -O-C
6
H
4
-CH
2
-.
Intermediates according to Claim 12, characterized 
in that they are chosen from: methyl N-(tert-butoxycarbonyl)-O-(benzyloxycarbonylmethyl)tyrosinate 

and 
methyl N-(tert-butoxycarbonyl)-O-(carboxymethyl)tyrosinate. 
Process for the preparation of the intermediates  
 

according to Claims 12 and 13, characterized in that it 
consists in reacting benzyl bromoacetate with a protected 

ω-hydroxy- or ω-mercapto-α-amino acid of formula: 

 
in which: 


the HZ'-group represents the HO-CH
2
-, HS-CH
2
-, 

 
or p-OH-C
6
H
4
-CH
2
- radical, 
R
1
 represents the tert-butyl radical or the benzyl 
radical, and 
R
2
 represents the methyl radical or the benzyl radical, 
in an organic solvent in the presence of lithium hydride 

and in optionally subjecting the product obtained of 
formula: 


 
to a deprotection by hydrogenation in methanol/methylene 

chloride solution in the presence of Pd/C with a view to 
obtaining the corresponding acid. 
Process according to Claim 14, characterized in 
that the protected ω-hydroxy-α-amino acid of formula (
5
) 
is methyl N-(tert-butyloxycarbonyl)tyrosinate. 
Cosmetic or dermatological composition, characterized 
in that it contains from 0.1 to 10% by weight of 

at least one cyclodextrin derivative according to 
Claims 1 to 3 or obtained according to Claims 4 to 11. 
Use of the cyclodextrin derivatives according to 
Claims 1 to 3 in the formation of inclusion complexes of 

active substances of lipophile nature or which are 
insoluble or unstable in aqueous medium. 
Use according to Claim 17, characterized in that 
the active substances are chosen from anti-oxidizing 

agents, compounds which are active against free radicals,  
 

anti-acne agents, anti-aging agents, anti-psoriatic 
agents, preserving agents, bactericidal agents, agents 

promoting hair regrowth, agents for hydrating and/or 
plasticizing the stratum corneum, sunscreening agents, 

agents for reconstituting the lipid barrier, hair dyes, 
depigmenting agents, anti-inflammatory agents, anti-viral 

agents, anti-cancer agents and steroids. 
Cosmetic or dermatological composition, characterized 
in that it contains an inclusion complex formed 

using a cyclodextrin derivative according to any one of 
Claims 1 to 3 and at least one active substance as 

defined according to Claim 18. 
Cosmetic or dermatological composition according 
to Claim 19, characterized in that it contains the 

inclusion complex in a proportion of between 0.1 and 30% 
with respect to the total weight of the composition. 
</CLAIMS>
</TEXT>
</DOC>
